AAAAAA

   
Results: 1-25 | 26-36 |
Results: 26-36/36
Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis
Authors: Glabinski, AR Krakowski, M Han, YL Owens, T Ransohoff, RM
Citation: Ar. Glabinski et al., Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis, J NEUROVIRO, 5(1), 1999, pp. 95-101
Tumor necrosis factor-alpha signals to the IFN-gamma receptor complex to increase Stat1 alpha activation
Authors: Han, YL Rogers, N Ransohoff, RM
Citation: Yl. Han et al., Tumor necrosis factor-alpha signals to the IFN-gamma receptor complex to increase Stat1 alpha activation, J INTERF CY, 19(7), 1999, pp. 731-740
Caveolin-3 upregulation activates beta-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease
Authors: Nishiyama, K Trapp, BD Ikezu, T Ransohoff, RM Tomita, T Iwatsubo, T Kanazawa, I Hsiao, KK Lisanti, MP Okamoto, T
Citation: K. Nishiyama et al., Caveolin-3 upregulation activates beta-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease, J NEUROSC, 19(15), 1999, pp. 6538-6548
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines
Authors: Ransohoff, RM
Citation: Rm. Ransohoff, Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines, J NEUROIMM, 98(1), 1999, pp. 57-68
Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors
Authors: Folcik, VA Smith, T O'Bryant, S Kawczak, JA Zhu, B Sakurai, H Kajiwara, A Staddon, JM Glabinski, A Chernosky, AL Tani, M Johnson, JM Tuohy, VK Rubin, LL Ransohoff, RM
Citation: Va. Folcik et al., Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors, J NEUROIMM, 97(1-2), 1999, pp. 119-128
Cerebrospinal fluid abnormalities in a phase III trial of Avonex (R) (IFN beta-1a) for relapsing multiple sclerosis
Authors: Rudick, RA Cookfair, DL Simonian, NA Ransohoff, RM Richert, JR Jacobs, LD Herndon, RM Salazar, AM Fischer, JS Granger, CV Goodkin, DE Simon, JH Bartoszak, DM Bourdette, DN Braiman, J Brownscheidle, CM Coats, ME Cohan, SL Dougherty, DS Kinkel, RP Mass, MK Munchsauer, FE O'Reilly, K Priore, RL Pullicino, PM Scherokman, BJ Wende, K Weinstock-Guttman, B Whitham, RH
Citation: Ra. Rudick et al., Cerebrospinal fluid abnormalities in a phase III trial of Avonex (R) (IFN beta-1a) for relapsing multiple sclerosis, J NEUROIMM, 93(1-2), 1999, pp. 8-14
TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA
Authors: Han, YL Zhou, ZHL Ransohoff, RM
Citation: Yl. Han et al., TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA, J IMMUNOL, 163(3), 1999, pp. 1435-1440
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
Authors: Sorensen, TL Tani, M Jensen, J Pierce, V Lucchinetti, C Folcik, VA Qin, SX Rottman, J Sellebjerg, F Strieter, RM Frederiksen, JL Ransohoff, RM
Citation: Tl. Sorensen et al., Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients, J CLIN INV, 103(6), 1999, pp. 807-815
Catalytic ally active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase
Authors: Rani, MRS Leaman, DW Han, YL Leung, S Croze, E Fish, EN Wolfman, A Ransohoff, RM
Citation: Mrs. Rani et al., Catalytic ally active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase, J BIOL CHEM, 274(45), 1999, pp. 32507-32511
Induction of beta-R1/I-TAC by interferon-beta requires catalytically active TYK2
Authors: Rani, MRS Gauzzi, C Pellegrini, S Fish, EN Wei, T Ransohoff, RM
Citation: Mrs. Rani et al., Induction of beta-R1/I-TAC by interferon-beta requires catalytically active TYK2, J BIOL CHEM, 274(4), 1999, pp. 1891-1897
Etiology and pathogenesis of multiple sclerosis
Authors: Sorensen, TL Ransohoff, RM
Citation: Tl. Sorensen et Rm. Ransohoff, Etiology and pathogenesis of multiple sclerosis, SEM NEUROL, 18(3), 1998, pp. 287-294
Risultati: 1-25 | 26-36 |